T4 2008 T3 2008 Variation M USD M USD M USD % Pharmaceuticals 1 562 1 743 –181 –10 Vaccins et Diagnostic 26 180 –154 –86 Sandoz 200 293 –93 –32 Consumer Health, activités poursuivies 190 292 –102 –35 Produits/charges nets de Corporate –298 –173 –125 72 Résultat opérationnel des activités poursuivies 1 680 2 335 –655 –28
Q4 2008 Q3 2008 Change USD m USD m USD m % Pharmaceuticals 1 562 1 743 –181 –10 Vaccines and Diagnostics 26 180 –154 –86 Sandoz 200 293 –93 –32 Consumer Health continuing operations 190 292 –102 –35 Corporate Income & Expense, net –298 –173 –125 72 Operating income from continuing operations 1 680 2 335 –655 –28